In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata
- PMID: 4597703
- PMCID: PMC444277
- DOI: 10.1128/AAC.2.3.114
In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata
Abstract
Spontaneous mutants of Candida albicans resistant to 5-fluorocytosine (5-FC) were isolated from a strain susceptible to 5-FC. These mutants were compared with 5-FC-resistant strains of C. albicans and Torulopsis glabrata isolated from patients treated with the drug and from untreated patients. Resistance to 5-FC was in all cases followed by a decreased susceptibility to 5-fluorouracil. Most strains were also more resistant to 5-fluorouridine and had a lowered incorporation of uridine. In one spontaneous mutant totally resistant to all three 5-fluoropyrimidines, the uridine monophosphate pyrophosphorylase activity was greatly decreased. The 5-FC-resistant strains were of two main phenotypic classes. Class one was unaffected by 5-FC at the highest concentration tested. The growth rate of strains belonging to the other class was markedly decreased by low concentrations of 5-FC, but these strains were still able to form colonies after 7 days of incubation on plates containing very high concentrations of the drug (2,000 mug/ml). The frequency of spontaneous mutation of a susceptible strain to 5-FC resistance was fairly high. The number of mutants growing on media containing 5-FC was unchanged by concentrations ranging from 25 to 500 mug/ml.
Similar articles
-
In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.Mycopathologia. 1981 Jan 30;73(1):39-41. doi: 10.1007/BF00443012. Mycopathologia. 1981. PMID: 7012631
-
In vitro activity of 5-fluorocytosine against Candida and Torulopsis species.Antimicrob Agents Chemother. 1973 Jan;3(1):9-14. doi: 10.1128/AAC.3.1.9. Antimicrob Agents Chemother. 1973. PMID: 4799552 Free PMC article.
-
[Sensitivity and resistance of Candida to 5-fluorocytosine, 5-fluorouracil and 5-fluorouridine. Relation to the ecology and serotype of C. albicans].C R Acad Hebd Seances Acad Sci D. 1974 Jan 28;278(5):605-8. C R Acad Hebd Seances Acad Sci D. 1974. PMID: 4211641 French. No abstract available.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans.Crit Rev Microbiol. 1987;15(1):45-56. doi: 10.3109/10408418709104447. Crit Rev Microbiol. 1987. PMID: 3319420 Review.
Cited by
-
Cryptococcal meningitis complicating systemic lupus erythematosus: two patients treated with flucytosine and amphotericin B.J Clin Pathol. 1977 Mar;30(3):254-61. doi: 10.1136/jcp.30.3.254. J Clin Pathol. 1977. PMID: 845273 Free PMC article.
-
Candida albicans septicaemia during first half of pregnancy successfully treated with 5-fluorocytosine.Br Med J. 1973 Nov 10;4(5888):337-8. doi: 10.1136/bmj.4.5888.337. Br Med J. 1973. PMID: 4202261 Free PMC article. No abstract available.
-
Innovations in Antifungal Drug Discovery among Cell Envelope Synthesis Enzymes through Structural Insights.J Fungi (Basel). 2024 Feb 22;10(3):171. doi: 10.3390/jof10030171. J Fungi (Basel). 2024. PMID: 38535180 Free PMC article. Review.
-
Diagnosis and management of cryptococcal meningitis in HIV-infected adults.Clin Microbiol Rev. 2023 Dec 20;36(4):e0015622. doi: 10.1128/cmr.00156-22. Epub 2023 Nov 28. Clin Microbiol Rev. 2023. PMID: 38014977 Free PMC article. Review.
-
New antifungal therapy in ophthalmology.Trans Am Ophthalmol Soc. 1973;71:233-42. Trans Am Ophthalmol Soc. 1973. PMID: 10949601 Free PMC article. Review. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources